Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing

The concept of allogeneic cell therapy was first presented over 60 years ago with hematopoietic stem cell transplantation. However, complications such as graft versus host disease (GVHD) and regimen-related toxicities remained as major obstacles. To maximize the effect of graft versus leukemia, whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Yoshiki, Hamano, Yasuharu, Shirane, Shuichi, Kinoshita, Shintaro, Azusawa, Yoko, Ando, Jun, Nakauchi, Hiromitsu, Ando, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773622/
https://www.ncbi.nlm.nih.gov/pubmed/35053386
http://dx.doi.org/10.3390/cells11020269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773622/
https://www.ncbi.nlm.nih.gov/pubmed/35053386
http://dx.doi.org/10.3390/cells11020269

Ejemplares similares